[go: up one dir, main page]

WO2000008155A3 - Human receptor-associated proteins - Google Patents

Human receptor-associated proteins Download PDF

Info

Publication number
WO2000008155A3
WO2000008155A3 PCT/US1999/017777 US9917777W WO0008155A3 WO 2000008155 A3 WO2000008155 A3 WO 2000008155A3 US 9917777 W US9917777 W US 9917777W WO 0008155 A3 WO0008155 A3 WO 0008155A3
Authority
WO
WIPO (PCT)
Prior art keywords
associated proteins
human receptor
hrap
provides
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/017777
Other languages
French (fr)
Other versions
WO2000008155A2 (en
Inventor
Jennifer L Hillman
Henry Yue
Preeti Lal
Y Tom Tang
Gina A Gorgone
Karl J Guegler
Neil C Corley
Mariah R Baughn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Priority to AU53392/99A priority Critical patent/AU5339299A/en
Priority to EP99939028A priority patent/EP1100908A2/en
Priority to JP2000563780A priority patent/JP2003528565A/en
Priority to CA002338385A priority patent/CA2338385A1/en
Publication of WO2000008155A2 publication Critical patent/WO2000008155A2/en
Publication of WO2000008155A3 publication Critical patent/WO2000008155A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention provides human receptor-associated proteins (HRAP) and polynucleotides which identify and encode HRAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HRAP.
PCT/US1999/017777 1998-08-07 1999-08-06 Human receptor-associated proteins Ceased WO2000008155A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU53392/99A AU5339299A (en) 1998-08-07 1999-08-06 Human receptor-associated proteins
EP99939028A EP1100908A2 (en) 1998-08-07 1999-08-06 Human receptor-associated proteins
JP2000563780A JP2003528565A (en) 1998-08-07 1999-08-06 Human receptor-related protein
CA002338385A CA2338385A1 (en) 1998-08-07 1999-08-06 Human receptor-associated proteins

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13088498A 1998-08-07 1998-08-07
US16006598P 1998-08-07 1998-08-07
US60/160,065 1998-08-07
US9870398P 1998-09-01 1998-09-01
US60/098,703 1998-09-01

Publications (2)

Publication Number Publication Date
WO2000008155A2 WO2000008155A2 (en) 2000-02-17
WO2000008155A3 true WO2000008155A3 (en) 2000-06-29

Family

ID=27378649

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/017777 Ceased WO2000008155A2 (en) 1998-08-07 1999-08-06 Human receptor-associated proteins

Country Status (1)

Country Link
WO (1) WO2000008155A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506569B1 (en) 1997-05-30 2003-01-14 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor TR10
EP1084142A4 (en) * 1998-06-11 2005-01-19 Smithkline Beecham Corp Gpr35a receptor
AU2001238151A1 (en) * 2000-02-09 2001-08-20 Millennium Pharmaceuticals, Inc. 19459 protein, a human g-protein coupled seven transmembrane receptor
AU2002256648A1 (en) * 2001-03-07 2002-09-19 Memorec Stoffel Gmbh - Medizinisch-Molekulare Entwicklung, Koln Palmityl transferases
CN100594935C (en) 2001-05-25 2010-03-24 人体基因组科学有限公司 Antibodies that immunospecifically bind to the TRAIL receptor
WO2005059546A2 (en) * 2003-12-12 2005-06-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35)
WO2005085867A2 (en) * 2004-02-27 2005-09-15 Pfizer Japan, Inc. Screening method for emulators of neural activity and digestive system using gpr35

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039511A2 (en) * 1995-06-05 1996-12-12 Incyte Pharmaceuticals, Inc. A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
EP0816496A2 (en) * 1996-06-24 1998-01-07 Roche Diagnostics GmbH T-cells specific for kidney carcinoma
WO1999003995A1 (en) * 1997-07-18 1999-01-28 Incyte Pharmaceuticals, Inc. T-cell receptor beta-like protein
WO1999041375A2 (en) * 1998-02-12 1999-08-19 Incyte Pharmaceuticals, Inc. Human receptor proteins

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039511A2 (en) * 1995-06-05 1996-12-12 Incyte Pharmaceuticals, Inc. A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
EP0816496A2 (en) * 1996-06-24 1998-01-07 Roche Diagnostics GmbH T-cells specific for kidney carcinoma
WO1999003995A1 (en) * 1997-07-18 1999-01-28 Incyte Pharmaceuticals, Inc. T-cell receptor beta-like protein
WO1999041375A2 (en) * 1998-02-12 1999-08-19 Incyte Pharmaceuticals, Inc. Human receptor proteins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
THIRKILL C E ET AL: "THE CANCER-ASSOCIATED RETINOPATHY ANTIGEN IS A RECOVERIN-LIKE PROTEIN", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE,US,HAGERSTOWN, MD, vol. 33, no. 10, pages 2768-2772, XP002910165, ISSN: 0146-0404 *
Y YOSHIKAI ET AL: "Sequence and expression of transcripts of the human T-cell receptor beta-chain genes", NATURE,GB,MACMILLAN JOURNALS LTD. LONDON, vol. 312, 6 December 1984 (1984-12-06), pages 521-524, XP002084031, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
WO2000008155A2 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
WO1999061471A3 (en) Human transmembrane proteins
WO2001012662A3 (en) Membrane associated proteins
WO2000015793A3 (en) Human gpcr proteins
WO2000018922A3 (en) Human carbohydrate-associated proteins
WO2000034477A3 (en) Neuron-associated proteins
WO2000021988A3 (en) Human ankyrin family protein
WO1999058692A3 (en) Human apoptosis associated proteins
WO2000029583A3 (en) Immunoglobulin superfamily proteins
WO2000012711A8 (en) Human membrane channel proteins
WO2000009709A3 (en) Proteases and associated proteins
WO2000012703A3 (en) Protein transport-associated molecules
WO2001020004A3 (en) Protein phosphatase and kinase proteins
WO2000017355A3 (en) Human cytoskeleton associated proteins
WO2000014251A3 (en) Human transferase proteins
WO2000052151A3 (en) Human secretory proteins
WO2000000594A3 (en) Human transferases
WO1999058558A3 (en) Cell signaling proteins
WO2000028032A3 (en) Human cell surface receptor proteins
WO1999061614A3 (en) Human socs proteins
WO2000031263A3 (en) Gtpase associated proteins
WO2000028045A3 (en) Human hydrolase proteins
WO2000008155A3 (en) Human receptor-associated proteins
WO2000065054A3 (en) Human membrane-associated proteins
WO2000001821A3 (en) Neurotransmission associated proteins
WO2000011171A3 (en) Human rna-associated proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2338385

Country of ref document: CA

Ref country code: CA

Ref document number: 2338385

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999939028

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999939028

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09762175

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1999939028

Country of ref document: EP